Tenaya Therapeutics Inc (NASDAQ: TNYA) is -37.65% lower on its value in year-to-date trading and has touched a low of $1.61 and a high of $7.01 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNYA stock was last observed hovering at around $2.09 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $2.02, the stock is -4.60% and -0.08% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.68 million and changing -3.35% at the moment leaves the stock -44.06% off its SMA200. TNYA registered 4.66% gain for a year compared to 6-month loss of -52.47%. The firm has a 50-day simple moving average (SMA 50) of $2.0296 and a 200-day simple moving average (SMA200) of $3.621625.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 15.43% gain in the last 1 month and extending the period to 3 months gives it a -30.10%, and is -19.20% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.24% over the week and 14.38% over the month.
Tenaya Therapeutics Inc (TNYA) has around 140 employees, a market worth around $160.02M and $0.00M in sales. Distance from 52-week low is 25.47% and -71.18% from its 52-week high. The company has generated returns on investments over the last 12 months (-94.44%).
The EPS is expected to grow by 19.57% this year
131.0 institutions hold shares in Tenaya Therapeutics Inc (TNYA), with institutional investors hold 74.76% of the company’s shares. The shares outstanding are 68.33M, and float is at 65.58M with Short Float at 8.00%. Institutions hold 73.88% of the Float.
The top institutional shareholder in the company is COLUMN GROUP LLC with over 9.4 million shares valued at $29.14 million. The investor’s holdings represent 11.6078 of the TNYA Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 7.62 million shares valued at $23.63 million to account for 9.4124 of the shares outstanding. The other top investors are CASDIN CAPITAL, LLC which holds 6.73 million shares representing 8.3141 and valued at over $20.87 million, while BLACKROCK INC. holds 5.0308 of the shares totaling 4.07 million with a market value of $12.63 million.
Tenaya Therapeutics Inc (TNYA) Insider Activity
The most recent transaction is an insider sale by Saito Chihiro, the company’s SVP, Accounting and Fin. Ops. SEC filings show that Saito Chihiro sold 2,363 shares of the company’s common stock on Aug 16 ’24 at a price of $2.89 per share for a total of $6840.0. Following the sale, the insider now owns 63241.0 shares.
Tenaya Therapeutics Inc disclosed in a document filed with the SEC on Aug 16 ’24 that Tingley Whittemore (Chief Medical Officer) sold a total of 7,428 shares of the company’s common stock. The trade occurred on Aug 16 ’24 and was made at $2.89 per share for $21500.0. Following the transaction, the insider now directly holds 0.11 million shares of the TNYA stock.
Still, SEC filings show that on Aug 16 ’24, Ali Faraz (Chief Executive Officer) disposed off 9,748 shares at an average price of $2.89 for $28216.0. The insider now directly holds 188,331 shares of Tenaya Therapeutics Inc (TNYA).
